Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

How Has The Metered Dose Inhaler Devices Market Growth Evolved From 2024 To 2025, And What’s Ahead?

In recent times, the market for metered dose inhaler devices has seen robust growth. Its value is supposed to grow from $15.46 billion in 2024 to $16.36 billion in 2025, showing a compound annual growth rate (CAGR) of 5.8%. This growth during the historical period is due to an increased incidence of diabetes, heightened demand for metered dose inhaler devices, an increase in the production of these devices, and a rise in the prevalence of COPD.

The market for metered dose inhaler devices is projected to experience robust expansion in the upcoming years, escalating to a market value of $20.29 billion by 2029 with a compound annual growth rate (CAGR) of 5.5%. This expansion during the forecasted duration is associated with the rising occurrence of chronic obstructive pulmonary diseases, an increase in asthma cases, growing incidences of infectious diseases, a rise in diabetes rates, and an escalated incidence of respiratory conditions. Key trends identified for this prediction period include the evolution of technology, pioneering therapies, regulatory endorsements, the invention of novel inhalers, and the incorporation of digital marketing strategies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20878&type=smp

Which Primay Drivers Are Accelerating Growth in the Metered Dose Inhaler Devices Market?

The anticipated rise in the occurrence of chronic obstructive pulmonary diseases is likely to fuel the expansion of the metered dose inhaler devices market. Chronic obstructive pulmonary disease (COPD), a lung disease marked by airflow blockage usually resulted from consistent exposure to irritants such as cigarette smoke, manifests symptoms like shortness of breath, coughing, and wheezing. The rise in chronic obstructive pulmonary disease (COPD) cases is due to reasons like tobacco consumption, air pollution, aging demographics, and delayed diagnosis or treatment. Metered dose inhaler (MDI) devices play a critical role in managing chronic obstructive pulmonary disease (COPD) by directly delivering medication to the lungs, offering fast relief and enhancing airflow. As per the National Institutes of Health, a US government agency, in December 2023, it predicts an escalation in COPD cases from 532 million in 2030 to a whopping 592 million by 2050. Consequently, the ascending incidence of chronic obstructive pulmonary diseases is promoting the surge in the metered dose inhaler devices market.

Which Primary Segments of the Metered Dose Inhaler Devices Market Are Driving Growth and Industry Transformations?

The metered dose inhaler devices market covered in this report is segmented –

1) By Type: Desktop Metered Dose Inhaler Devices, Portable Metered Dose Inhaler Devices, Other Types

2) By Distribution Channel: Online, Offline

3) By Application: Asthma, Chronic Obstructive Pulmonary Disease, Other Applications

4) By End-User: Hospitals, Clinics, Homecare Settings, Other End Users

Subsegments:

1) By Desktop Metered Dose Inhaler Devices: Standard desktop MDI devices, High-performance desktop MDI devices, Smart desktop MDI devices

2) By Portable Metered Dose Inhaler Devices: Conventional portable MDI devices, Advanced portable MDI devices, Smart portable MDI devices

3) By Other Types: Nebulizer-Based MDI devices, Dry powder inhaler (DPI) combined devices, Soft mist inhaler (SMI) devices, Other specialized MDI devices

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=20878&type=smp

Which Regions Are Key Players in the Growth of the Metered Dose Inhaler Devices Market?

North America was the largest region in the metered dose inhaler devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metered dose inhaler devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Market Trends in the Metered Dose Inhaler Devices Market Over the Coming Years?

Leading businesses in the metered dose inhaler devices industry are prioritizing the development of high-tech solutions such as pressurized metered dose inhalers to increase the efficiency of medication delivery and boost patient adherence. These pressurized metered-dose inhalers (pMDIs) are breathing aids which provide a specific amount of medicine in aerosol form using pressurized propellants. For instance, in July 2023, Lupin Limited, a pharmaceutical firm from India, introduced its product Luforbec 100/6, a pressurized metered dose inhaler (pMDI), in Germany for adult asthma and chronic obstructive pulmonary disease (COPD) treatment. This product merges beclometasone (100 µg) and formoterol (6 µg), offering an efficacious solution for patients needing combination therapy. Remarkably, Luforbec costs about 47% less than the fixed reference price, maximizing its availability. As asthma impacts roughly 5% of adults in Germany, this launch accentuates Lupin’s dedication to cater to vital healthcare requirements and enhance patient outcomes in respiratory care.

View the full report here:

https://www.thebusinessresearchcompany.com/report/metered-dose-inhaler-devices-global-market-report

What Parameters Are Used to Define the Metered Dose Inhaler Devices Market?

Metered dose inhaler (MDI) devices refer to medical devices designed for delivering precise doses of aerosolized medication directly to the lungs through inhalation. These devices are commonly used in the treatment of respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other breathing disorders.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20878

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model